Synopsis: Jenburkt Pharmaceuticals Limited, a Pharma Stock, reports 28.27% QoQ revenue growth and a 30.42% QoQ net profit surge in Q2 FY26 results. This micro-cap pharma stock, engaged in manufacturing, producing, developing, and marketing pharmaceutical formulations,...
Synopsis: JFL Life Sciences shares rose after receiving a ₹29.99 crore order from JD Healthcare for Merilyzer Quantilyte Machines. This Penny Pharma Stock, engaged in manufacturing and marketing pharmaceutical products, including beta-lactam dry powder injections,...
Synopsis:Shares rose 3% following a foreign investor’s block deal. Q1FY26 revenue grew 13% despite a 39% profit decline. Strong momentum in Pharma CDMO, API, and specialty chemicals, robust project pipeline, global partnerships, and capacity expansions underpin...
Synopsis: Mankind Pharma Ltd, remained in focus after announcing a Rs. 797 crore acquisition to strengthen its women’s health portfolio. The strategic buyout, executed through a slump sale, underscores the company’s focus on expanding branded generics in the...
Synopsis: Senores Pharmaceuticals is well-positioned to remain insulated from recent US tariffs on branded and patented drugs due to its fully operational US manufacturing facility. With robust CDMO/CMO operations, a diversified regulated markets portfolio, and a...
Synopsis: Jubilant Pharmova’s wholly-owned subsidiary, Jubilant HollisterStier, launched a new $132 million Sterile Fill & Finish line in Spokane, boosting US CDMO capacity, driving revenue growth, and strengthening global market positioning. Can Jubilant Pharmova...
Synopsis: Natco Pharma surged 6 percent after the Delhi High Court dismissed Roche’s appeal, clearing the way for the launch of its affordable generic Risdiplam, improving treatment access for SMA patients. A pharmaceutical stock surged 6 percent on Thursday after a...
Synopsis: As of September 2025, Tata Mutual Fund added fresh stakes in a pharma sector company. Tata Mutual Fund, part of the trusted Tata Group, was set up in 1994 and offers a wide range of investment options across equity, debt, and hybrid funds. Known for its...
Synopsis: Emcure Pharmaceuticals surged nearly five percent after acquiring the remaining 20.42 percent stake in Zuventus Healthcare, making it a wholly-owned subsidiary. A pharmaceutical stock gained nearly five percent, following news of a strategic acquisition....
Synopsis: Sun Pharmaceutical Industries Limited is in focus after Citi has assigned a new target price with a buy rating with an upside of more than 34%. Citi, one of the leading global brokerage firms, has set a new target price for a Pharma stock, reflecting its...
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
